What laboratory monitoring, if any, is recommended for patients starting and continuing on lebrikizumab?
Featuring James Del Rosso, DO | Clinical Advisor | Adjunct Clinical Professor (Dermatology) Touro University Nevada Henderson, NV Research Director/ Principal Investigator/ Clinical Dermatologist JDR Dermatology Research Las Vegas, NV | Published October 01, 2025
Related Media
Powered by Polaris TM